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In the last two decades, several cardiac surgical procedures have
become standard, and the results can be considered good or even
excellent. Yet, unless a procedure is considered 100% safe and efﬁ-
cient, cardiothoracic surgeons should not be satisﬁed with a ‘good
enough’ mentality, but must perpetually strive for further improve-
ment. One critical limitation in this endeavour is the assessment of
the results, because a signiﬁcant improvement in morbidity and
mortality rates may be difﬁcult to detect if these end-points
already occur at very low rates. Randomized controlled trials
(RCTs) remain the gold standard for reaching Level 1 of evidence.
By carefully selecting the end-points as well as the inclusion and
exclusion criteria, RCTs aim to rapidly provide solid information
regarding a new therapeutic approach (percutaneous intervention,
surgical procedure, device or drug performance) that may eventu-
ally be further extrapolated to a larger (or more global) population.
However, results of RCTs may be biased because of the selection
of ‘best-performer’ institutions and, therefore, that of such powerful
studies may not adequately represent the average level of care.
This is where registries may give a better picture of the real world:
but, if poorly conducted, they may also lead to a distorted under-
standing of the reality. In the current issue of the European Journal
of Cardio-Thoracic Surgery, Hickey et al. review various critical
aspects of administering a registry [1]. The authors highlight the
growing interest in registries and the potential they offer for future
clinical, but also socio-economical, developments.
In its ideal form, a registry should provide enough evidence to
support the development of individuals or collectivities and to
reﬂect the changes in performances. Indeed, one critical asset of
registries is the principle of reciprocity, requiring each participant
to comprehensively and unreservedly include all of his/her data.
In exchange, all participants should be granted access to a larger
source of information, by means of which they would be
encouraged to learn from each other and to improve the quality
of their own institution. The unrestricted use of these large data-
bases will, however, remain sub-optimal as long as not all rele-
vant data of all consecutive patients constituting the speciﬁc
registry (transcatheter aortic valve implementation, coronary
artery bypass grafting and others) are included. Geographically,
registries should also be as broad as possible or at least be con-
ceived so that different entities are compatible (same criteria
and deﬁnitions) and can be technically merged into one larger
database. Finally, registries should allow for longitudinal analysis
in order to provide results over the long-term [2, 3].
To achieve this ambitious but inevitable objective, critical rules
must be discussed, accepted and sooner or later implemented.
Some already exist and are obligatory, such as the legal and ethical
structures (which may vary from country to country), and others
are suggested by guidelines or recommendations, such as the way
data should be managed, but several are yet to be clariﬁed.
Among them, the quality of the ‘raw data’ is probably the most
critical issue. Currently, and with only few exceptions, submission
of data is facultative, and data are not subjected to obligatory
third-party checks (independent audits). Inconsistencies, missing
information, duplication or transcription errors, among others, can
be checked and corrected after they have been submitted to the
registry; however, the truth behind submitted data remains, for
most centres, a matter of trust. One major exception—as an
example—is the registry of the European Congenital Heart Surgery
Association (ECHSA), running for more than 10 years, and that
includes independent audits to allow institutional certiﬁcation.
Typically, the surgeons themselves or locally dedicated persons
(database managers) with varying experience and skills manage
their own institutional database and, most of the time, there is no
local audit or control process deﬁned. One can reasonably suspect
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that a critical selection bias is introduced even before the data
entry. Consequently, even with the best cleaning and statistical pro-
cesses, a legitimate doubt regarding the interpretation of the regis-
try data remains. Cardiothoracic surgeons, obviously better than
others, are aware of this limitation but remain, at least some of
them, only partially motivated to participate in the process of regis-
tering. It is clear that an extra effort is required, even if the process
is time-consuming and costly. Nevertheless, large registries are cur-
rently managed by professionals who are able to periodically
deliver detailed reports with instructive information. Importantly,
this information is nowadays increasingly relevant and considered
for purposes other than only clinical, namely for strategic, political
and economical health decisions. Speciﬁc registries may be
compared with other registries (demographics for example) for
non-specialists to draw conclusions to better organize health-care
provision and ﬁnally to better serve the population. It is therefore a
critical duty of each surgeon or clinic to accept the responsibility of
providing the most accurate and exhaustive data set they can.
There is extensive literature not only available on the neces-
sity, but also the quality of national and international registries.
As the former president of the American College of Cardiology
wrote in an Editorial, ‘Registries serve a different purpose: at
their best, they serve to measure what is happening in the real
world of patients irrespective of whether those patients are can-
didates for the randomized clinical trials or not’ [4].
The information currently available from registries is the result
of visionary surgeons who initiated the work a few decades ago,
and the numerous registry-based reports that have been pub-
lished in the scientiﬁc literature during the last years prove that
this effort was worthwhile [5]. It is now our turn to perpetuate or
better implement this work in order to provide the next gener-
ation of cardiothoracic surgeons with additional, more accurate
information that will hopefully help them as well as other care-
providers to reach better health-management strategies.
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